Topical skin formulations of a pharmaceutically acceptable salt of ruxolitinib
TW202626049APending Publication Date: 2026-07-01INCYTE CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132436
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-28
- Filing Date
- 2025-08-26
- Publication Date
- 2026-07-01
Abstract
This invention relates to topical skin formulations comprising a pharmaceutically acceptable salt of ruxolitinib, and use in the treatment of skin disorders.
Need to check novelty before this filing date? Find Prior Art